|
|
12 Emily Street
Cambridge, MA 02139 USA
phone:617-995-7000
fax:617-995-7050
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.elixirpharm.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutics to treat age-related diseases. |
|
| Management |
| Paul M. Martha, M.D., CEO and Chief Medical Officer; Peter S. DiStefano, Ph.D., Chief Scientific Officer; Karen Roberts, Vice President Finance and Administration |
| |
|
|
| |
|
| Keywords |
| age-related disease, metabolic, diatete, obesity |
|
|
|
| Description |
|
Elixir Pharmaceuticals, Inc. develops and commercializes therapeutics to treat age-related diseases, with a focus on metabolic diseases such as diabetes and obesity. |
|
| Technology / Differentiation |
| Elixir has assembled a comprehensive technology platform in the biology and molecular genetics of aging and disease: 1. The largest commercially consented collection of centenarian genomes and medical histories, 2. Laboratory organism models of human aging and metabolic disease, 3. The capability to predictably translate information from laboratory organisms to human genes, physiological pathways, diseases and drugs, and 4. The capability to validate our drug development pipeline in diabetes and obesity, among other age related diseases. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members